Rigel Pharmaceuticals, Inc. (RIGL)
42.05
+0.83
(+2.01%)
USD |
NASDAQ |
Dec 11, 16:00
42.07
+0.02
(+0.05%)
After-Hours: 20:00
Rigel Pharmaceuticals Research and Development Expense (TTM): 28.24M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Eli Lilly & Co. | 12.56B |
| Catalyst Pharmaceuticals, Inc. | 14.70M |
| Amicus Therapeutics, Inc. | 142.29M |
| Perspective Therapeutics, Inc. | 61.22M |
| Nektar Therapeutics | 116.36M |